Skip to content

Children's Blood Draws: Lavender Study

The Effectiveness of Lavender Essence in Reducing Pain and Fear in Children During Blood Draws; A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06933771
Enrollment
102
Registered
2025-04-18
Start date
2018-12-15
Completion date
2023-09-15
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nursing Caries, Pain Management

Keywords

PAİN, FEAR

Brief summary

The aim of this study is to show the effect of lavender scent used to reduce pain and fear during blood collection in children aged 7-14.

Detailed description

The children in the experimental group were given lavender scent before the blood collection procedure. No additional intervention was made to the children in the control group. The pain and fear scores of both groups were evaluated.

Interventions

OTHERLAVENDER ESSENCE GROUP

Parents stood on the left side, easily visible to the child. The sole routine method used to reduce pain in the blood collection unit of the hospital in which the study was conducted is the presence of parents during the procedure. In this study, all children in both intervention and control groups were accompanied by their parents. Afterwards, the researcher explained to the children in the intervention group and their parents how to apply the lavender essence and what kind of a plant lavender is, and showed the bottle of essential oil to be used during the procedure. A 5x5 cm sponge with 2 drops of almond oil that contains 1% lavender essence was located on the shoulder of the children to smell for 5 minutes.

OTHERCONTROL GROUP

Parents stood on the left side, easily visible to the child. The sole routine method used to reduce pain in the blood collection unit of the hospital in which the study was conducted is the presence of parents during the procedure. In this study, all children in both intervention and control groups were accompanied by their parents. Routine nursıng care provıed.

Sponsors

Corlu State Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

LAVENDER ESSENCE GROUP - CONTROL GROUP

Eligibility

Sex/Gender
ALL
Age
7 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

children between the ages of 7-14 who applied to the blood collection unit, who had no mental neurological, hearing, speech, vison disorders

Exclusion criteria

who were not allergic to lavender essence, who were not diagnosed with asthma, allergies, epilepsy, dermatitis who had not taken analgesics in the last 6 hours were included in the study

Design outcomes

Primary

MeasureTime frameDescription
Child Medical Fear Scale (CMFS)9 MONTHSIt is a 3-point Likert type scale that includes 29 items expressing the medical fears of children. For each item, the child is asked to choose one of the following responses: not all afraid (1), a little afraid (2), very afraid (3). The scale has 4 subscale dimensions which are procedural fears, environmental fears, intrapersonal fears and interpersonal fears. The total score that can be obtained on the scale ranges from 29 as the lowest to 87 as the highest . Children who score between 0-29 points are considered not afraid while the children who score between 29-58 points are considered a little afraid, and children who score between 58-87 points are considered very afraid.
Wong-Baker FACES Pain Rating Scale (WBFPRS)9 MONTHSOn the scale, there are 6 facial expressions that are presented on a horizontal plane and scored from 0 to 10. The happy facial expression on the far left represents a score of 0, meaning doesn't hurt at all and the crying facial expression on the far right represents a score of 10, meaning hurts as much as you can imagine

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026